PXD000439 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | Reconstructing targetable pathways in lung cancer by integrating diverse omics data |
Description | We profile transcriptome, proteome and phosphoproteome in a panel of non-small cell lung cancer (NSCLC) cell lines in order to reconstruct targetable networks associated with KRAS dependency. We develop a two-step bioinformatics strategy addressing the challenge of integrating these disparate datasets. We first define an “abundance-score” combining transcript, protein and phospho-protein abundances to nominate differentially abundant proteins and then use the Prize Collecting Steiner Tree algorithm to identify functional sub-networks. We identify three modules centered on KRAS and MET, LCK and PAK1 and Beta-catenin. We validate activation of these proteins in KRAS-dependent cells and perform functional studies defining LCK as a critical gene for cell proliferation in KRAS-dependent but not KRAS-independent NSCLCs. These results are the first evidence that suggest LCK as a potential druggable target protein in KRAS-dependent lung cancers. Data analysis: Raw spectra files were converted to mzXML using ReadAW. The mzXML files were searched using X!Tandem with the k-score plug-in. The proteomic searches were performed using the following options: allow up to 2 missed tryptic cleavages, a parent ion tolerance window of -1 to +4 Daltons, and a fragment ion tolerance of 0.8 Da. The following variable modifications were allowed: phosphorylation of Serine, Threonine, and Tyrosine (+79.966331@[STY]), oxidation of Methionine (+15.994920@M), and carbamidomethylation of Cysteine (+57.021460@C). All protein searches were performed using the Human Refseq protein database (release 47). Appended to this database were common proteomic contaminants and reversed protein sequences to serve as decoys. The X!Tandem results were then post processed with PeptideProphet and ProteinProphet. |
HostingRepository | PRIDE |
AnnounceDate | 2014-07-24 |
AnnouncementXML | Submission_2014-07-24_03:50:02.xml |
DigitalObjectIdentifier | |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Unsupported dataset by repository |
PrimarySubmitter | Damian Fermin |
SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: 9606; |
ModificationList | 2-pyrrolidone-5-carboxylic acid (Glu); O-phospho-L-serine; monohydroxylated residue; O4'-phospho-L-tyrosine; O-phospho-L-threonine; S-carboxamidomethyl-L-cysteine; 2-pyrrolidone-5-carboxylic acid (Gln) |
Instrument | LTQ Velos |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2013-09-02 01:53:24 | ID requested | |
1 | 2014-06-24 03:01:38 | announced | |
2 | 2014-07-23 06:54:07 | announced | Updated publication reference for PubMed record(s): 24135919. |
⏵ 3 | 2014-07-24 03:50:03 | announced | Updated project metadata. |
Publication List
Balbin OA, Prensner JR, Sahu A, Yocum A, Shankar S, Malik R, Fermin D, Dhanasekaran SM, Chandler B, Thomas D, Beer DG, Cao X, Nesvizhskii AI, Chinnaiyan AM, Reconstructing targetable pathways in lung cancer by integrating diverse omics data. Nat Commun, 4():2617(2013) [pubmed] |
Keyword List
curator keyword: Biomedical |
submitter keyword: human,proteome,lung cancer,KRAS,cancer,cancer by KRAS dependency,phosphoproteome |
Contact List
Damian Fermin |
contact affiliation | Pathology |
contact email | dfermin@umich.edu |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/06/PXD000439 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD000439
- Label: PRIDE project
- Name: Reconstructing targetable pathways in lung cancer by integrating diverse omics data